Robert Spiegel
Direktor/Vorstandsmitglied bei GERON CORPORATION
Vermögen: 633 572 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Paul McBarron | M | 63 | 22 Jahre | |
| David Sidransky | M | 64 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | 10 Jahre |
| Ken Berlin | M | 59 | 6 Jahre | |
| Frank Bedu-Addo | M | 59 | 5 Jahre | |
| Murray Goldberg | M | 79 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | 7 Jahre |
| Roni Mamluk | M | 57 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | 7 Jahre |
| John Scarlett | M | 73 | 13 Jahre | |
| Sol Barer | M | 76 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | 9 Jahre |
| Vered Bisker-Leib | M | 53 | 4 Jahre | |
| Ramtin Agah | M | 58 | 15 Jahre | |
| Shaun Bagai | M | 47 | 10 Jahre | |
| Richard Pasternak | M | 75 |
Weill Cornell Medical College
Yale University
| 8 Jahre |
| Yuval Cabilly | M | 44 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | 10 Jahre |
| Jerome Zeldis | M | 74 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | 12 Jahre |
| Spiro Rombotis | M | 65 | 27 Jahre | |
| Andrew Einhorn | M | 64 |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | 10 Jahre |
| Dilip Shantilal Shanghvi | M | 68 | 18 Jahre | |
| Steinberg Sarit | F | - |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | 9 Jahre |
| Christopher Henney | M | 83 | 18 Jahre | |
| Brian Schwartz | M | 52 | 4 Jahre | |
| Gary Gordon | M | 71 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | - |
| Elizabeth O'Farrell | F | 59 | 5 Jahre | |
| Ronald Kocak | M | 67 | 3 Jahre | |
| Costantino Iadecola | M | - |
Weill Cornell Medical College
| - |
| Rajamannar Thennati | M | 63 | 17 Jahre | |
| Donald J. D'Amico | M | - |
Weill Cornell Medical College
| - |
| Lorraine Gudas | F | - |
Weill Cornell Medical College
| - |
| Karin Walker | F | 60 | 4 Jahre | |
| David Cutler | M | - | - | |
| Anilkumar Raghavan | M | 54 | 10 Jahre | |
| Samuel Barker | M | 81 | 10 Jahre | |
| Stephanie Davis | F | 60 | 5 Jahre | |
| Jacqueline Li | F | - | 7 Jahre | |
| Ferzaan Engineer | M | 61 | 7 Jahre | |
| Michelle Robertson | F | 57 | 1 Jahre | |
| Kajal Damania | F | - | 1 Jahre | |
| Igor Gitelman | M | 48 | 4 Jahre | |
| Dawn Bir | F | 53 | 5 Jahre | |
| Aron Feingold | M | - | 2 Jahre | |
| Martin Rexroad | M | - | 11 Jahre | |
| Gidon Zairi | M | - |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | 10 Jahre |
| Jinn Wu | M | 75 | 17 Jahre | |
| Glenn Steele | M | 79 | 9 Jahre | |
| Andrew Grethlein | M | 59 | 12 Jahre | |
| Roni Appel | M | 57 | 20 Jahre | |
| Samir Khleif | M | 60 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | - |
| Yiu Nam Lau | M | 63 | 21 Jahre | |
| Una Ryan | M | 82 | 12 Jahre | |
| Steven Adams | M | - | 11 Jahre | |
| V. Lawlis | M | 72 | 12 Jahre | |
| Andres Gutiérrez | M | 63 | 6 Jahre | |
| Susan Molineaux | M | 70 | 12 Jahre | |
| John Vierling | M | 78 | 5 Jahre | |
| Gaurav Aggarwal | M | 51 | 1 Jahre | |
| John McDonald | M | 63 | 2 Jahre | |
| Laurence Marton | M | 80 | 12 Jahre | |
| Sudhir Vrundavandas Valia | M | 67 | 18 Jahre | |
| Kwan Hung Tsang | M | 60 | 6 Jahre | |
| Kristen MacFarlane | F | 60 | 6 Jahre | |
| Derace L. Schaffer | M | 76 |
Weill Cornell Medical College
| - |
| Scott Samuels | M | 54 | - | |
| Bhavna Gautam Doshi | F | 70 | 10 Jahre | |
| Jordan Kanfer | M | 54 | 5 Jahre | |
| Melissa Nirenberg | F | - |
Weill Cornell Medical College
| - |
| Daniel Winter Goodman | M | 63 |
Weill Cornell Medical College
| - |
| Larry Schlossman | M | - |
Weill Cornell Medical College
| - |
| James B Bussel | M | - |
Weill Cornell Medical College
| - |
| Eric Pauwels | M | 63 | 9 Jahre | |
| Thomas H. Lee | M | 70 |
Weill Cornell Medical College
| - |
| Antonio M. Gotto | M | 88 |
Weill Cornell Medical College
| 27 Jahre |
| Mozah bint Nasser Al-Missned | F | 66 |
Weill Cornell Medical College
| - |
| Scott T. Tagawa | M | - |
Weill Cornell Medical College
| 17 Jahre |
| David Scheinberg | M | 68 |
Weill Cornell Medical College
| 25 Jahre |
| Nelson Peltz | M | 81 |
Weill Cornell Medical College
| - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| David Greenwood | M | 72 | 16 Jahre | |
| Olivia Bloom | F | 55 | 29 Jahre | |
| Debashis Dey | M | - | - | |
| Andrew Saik | M | 54 |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 3 Jahre |
| W. Middlekauff | M | 63 |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | - |
| Albert Marchio | M | 72 |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 4 Jahre |
| Dan Seiver | M | - |
Yale University
| 5 Jahre |
| Steven R. Deitcher | M | 59 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 6 Jahre |
| Marcio Souza | M | 45 | 6 Jahre | |
| Ho Young Huh | M | 54 | 8 Jahre | |
| Yossi Maimon | M | 53 | 4 Jahre | |
| Robert Macdonald | M | 62 |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 9 Jahre |
| Teresa Bair | F | 53 | 6 Jahre | |
| David J. Earp | M | 59 | 13 Jahre | |
| David C. U'Prichard | M | 75 | 16 Jahre | |
| Alexander E. Barkas | M | 76 | 19 Jahre | |
| Randolph Steer | M | 74 | 5 Jahre | |
| Matthias Alder | M | 59 | 3 Jahre | |
| Alex Driggs | M | 48 | 3 Jahre | |
| Maureen O'Connell | F | 62 | 5 Jahre | |
| Emily Hill | F | 44 | - | |
| Kurt J. W. Andrews | M | 54 | 9 Jahre | |
| Gene C. Mack | M | 50 |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 2 Jahre |
| William Ashton | M | 73 | 6 Jahre | |
| Ronald Renaud | M | 55 | 3 Jahre | |
| Randoll Sze | M | 43 | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 87 | 87,00% |
| Israel | 16 | 16,00% |
| Indien | 8 | 8,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Robert Spiegel
- Persönliches Netzwerk
